Gadolinium-based contrast media also referred to magnetic resonance imaging contrast media or dyes are chemical substances that are used in magnetic resonance imaging based diagnostics.
The global Gadolinium-based Contrast Media market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadolinium-based Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadolinium-based Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadolinium-based Contrast Media include Bayer AG, GE Healthcare(GE), Guerbet, Lantheus Medical Imaging, Bracco Diagnostics Inc., Trivitron Healthcare, Nano Therapeutics Pvt. Ltd., Nanoscan Imaging LLC and Jodas Expoim Pvt Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadolinium-based Contrast Media, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadolinium-based Contrast Media.
Report Scope
The Gadolinium-based Contrast Media market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadolinium-based Contrast Media market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadolinium-based Contrast Media manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Bayer AG
GE Healthcare(GE)
Guerbet
Lantheus Medical Imaging
Bracco Diagnostics Inc.
Trivitron Healthcare
Nano Therapeutics Pvt. Ltd.
Nanoscan Imaging LLC
Jodas Expoim Pvt Ltd
Magnus Health(Veracross LLC)
Spago Nanomedical
Segment by Type
Extracellular Agents
Blood Pool Agents
Hepatobiliary Agents
Segment by Application
Cardiovascular
Neurology
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadolinium-based Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadolinium-based Contrast Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Gadolinium-based Contrast Media 麻豆原创 Overview
1.1 Product Overview and Scope of Gadolinium-based Contrast Media
1.2 Gadolinium-based Contrast Media Segment by Type
1.2.1 Global Gadolinium-based Contrast Media 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Extracellular Agents
1.2.3 Blood Pool Agents
1.2.4 Hepatobiliary Agents
1.3 Gadolinium-based Contrast Media Segment by Application
1.3.1 Global Gadolinium-based Contrast Media 麻豆原创 Value by Application: (2024-2030)
1.3.2 Cardiovascular
1.3.3 Neurology
1.3.4 Cancer
1.3.5 Others
1.4 Global Gadolinium-based Contrast Media 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Gadolinium-based Contrast Media Revenue 2019-2030
1.4.2 Global Gadolinium-based Contrast Media Sales 2019-2030
1.4.3 Global Gadolinium-based Contrast Media 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gadolinium-based Contrast Media 麻豆原创 Competition by Manufacturers
2.1 Global Gadolinium-based Contrast Media Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Gadolinium-based Contrast Media Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Gadolinium-based Contrast Media Average Price by Manufacturers (2019-2024)
2.4 Global Gadolinium-based Contrast Media Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadolinium-based Contrast Media, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadolinium-based Contrast Media, Product Type & Application
2.7 Gadolinium-based Contrast Media 麻豆原创 Competitive Situation and Trends
2.7.1 Gadolinium-based Contrast Media 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gadolinium-based Contrast Media Players 麻豆原创 Share by Revenue
2.7.3 Global Gadolinium-based Contrast Media 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gadolinium-based Contrast Media Retrospective 麻豆原创 Scenario by Region
3.1 Global Gadolinium-based Contrast Media 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gadolinium-based Contrast Media Global Gadolinium-based Contrast Media Sales by Region: 2019-2030
3.2.1 Global Gadolinium-based Contrast Media Sales by Region: 2019-2024
3.2.2 Global Gadolinium-based Contrast Media Sales by Region: 2025-2030
3.3 Global Gadolinium-based Contrast Media Global Gadolinium-based Contrast Media Revenue by Region: 2019-2030
3.3.1 Global Gadolinium-based Contrast Media Revenue by Region: 2019-2024
3.3.2 Global Gadolinium-based Contrast Media Revenue by Region: 2025-2030
3.4 North America Gadolinium-based Contrast Media 麻豆原创 Facts & Figures by Country
3.4.1 North America Gadolinium-based Contrast Media 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gadolinium-based Contrast Media Sales by Country (2019-2030)
3.4.3 North America Gadolinium-based Contrast Media Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadolinium-based Contrast Media 麻豆原创 Facts & Figures by Country
3.5.1 Europe Gadolinium-based Contrast Media 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gadolinium-based Contrast Media Sales by Country (2019-2030)
3.5.3 Europe Gadolinium-based Contrast Media Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadolinium-based Contrast Media 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Gadolinium-based Contrast Media 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gadolinium-based Contrast Media Sales by Country (2019-2030)
3.6.3 Asia Pacific Gadolinium-based Contrast Media Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadolinium-based Contrast Media 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Gadolinium-based Contrast Media 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gadolinium-based Contrast Media Sales by Country (2019-2030)
3.7.3 Latin America Gadolinium-based Contrast Media Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadolinium-based Contrast Media 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Gadolinium-based Contrast Media 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gadolinium-based Contrast Media Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gadolinium-based Contrast Media Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadolinium-based Contrast Media Sales by Type (2019-2030)
4.1.1 Global Gadolinium-based Contrast Media Sales by Type (2019-2024)
4.1.2 Global Gadolinium-based Contrast Media Sales by Type (2025-2030)
4.1.3 Global Gadolinium-based Contrast Media Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Gadolinium-based Contrast Media Revenue by Type (2019-2030)
4.2.1 Global Gadolinium-based Contrast Media Revenue by Type (2019-2024)
4.2.2 Global Gadolinium-based Contrast Media Revenue by Type (2025-2030)
4.2.3 Global Gadolinium-based Contrast Media Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Gadolinium-based Contrast Media Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gadolinium-based Contrast Media Sales by Application (2019-2030)
5.1.1 Global Gadolinium-based Contrast Media Sales by Application (2019-2024)
5.1.2 Global Gadolinium-based Contrast Media Sales by Application (2025-2030)
5.1.3 Global Gadolinium-based Contrast Media Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Gadolinium-based Contrast Media Revenue by Application (2019-2030)
5.2.1 Global Gadolinium-based Contrast Media Revenue by Application (2019-2024)
5.2.2 Global Gadolinium-based Contrast Media Revenue by Application (2025-2030)
5.2.3 Global Gadolinium-based Contrast Media Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Gadolinium-based Contrast Media Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer AG Gadolinium-based Contrast Media Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 GE Healthcare(GE)
6.2.1 GE Healthcare(GE) Corporation Information
6.2.2 GE Healthcare(GE) Description and Business Overview
6.2.3 GE Healthcare(GE) Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Healthcare(GE) Gadolinium-based Contrast Media Product Portfolio
6.2.5 GE Healthcare(GE) Recent Developments/Updates
6.3 Guerbet
6.3.1 Guerbet Corporation Information
6.3.2 Guerbet Description and Business Overview
6.3.3 Guerbet Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guerbet Gadolinium-based Contrast Media Product Portfolio
6.3.5 Guerbet Recent Developments/Updates
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Corporation Information
6.4.2 Lantheus Medical Imaging Description and Business Overview
6.4.3 Lantheus Medical Imaging Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lantheus Medical Imaging Gadolinium-based Contrast Media Product Portfolio
6.4.5 Lantheus Medical Imaging Recent Developments/Updates
6.5 Bracco Diagnostics Inc.
6.5.1 Bracco Diagnostics Inc. Corporation Information
6.5.2 Bracco Diagnostics Inc. Description and Business Overview
6.5.3 Bracco Diagnostics Inc. Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bracco Diagnostics Inc. Gadolinium-based Contrast Media Product Portfolio
6.5.5 Bracco Diagnostics Inc. Recent Developments/Updates
6.6 Trivitron Healthcare
6.6.1 Trivitron Healthcare Corporation Information
6.6.2 Trivitron Healthcare Description and Business Overview
6.6.3 Trivitron Healthcare Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Trivitron Healthcare Gadolinium-based Contrast Media Product Portfolio
6.6.5 Trivitron Healthcare Recent Developments/Updates
6.7 Nano Therapeutics Pvt. Ltd.
6.6.1 Nano Therapeutics Pvt. Ltd. Corporation Information
6.6.2 Nano Therapeutics Pvt. Ltd. Description and Business Overview
6.6.3 Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Product Portfolio
6.7.5 Nano Therapeutics Pvt. Ltd. Recent Developments/Updates
6.8 Nanoscan Imaging LLC
6.8.1 Nanoscan Imaging LLC Corporation Information
6.8.2 Nanoscan Imaging LLC Description and Business Overview
6.8.3 Nanoscan Imaging LLC Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nanoscan Imaging LLC Gadolinium-based Contrast Media Product Portfolio
6.8.5 Nanoscan Imaging LLC Recent Developments/Updates
6.9 Jodas Expoim Pvt Ltd
6.9.1 Jodas Expoim Pvt Ltd Corporation Information
6.9.2 Jodas Expoim Pvt Ltd Description and Business Overview
6.9.3 Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Product Portfolio
6.9.5 Jodas Expoim Pvt Ltd Recent Developments/Updates
6.10 Magnus Health(Veracross LLC)
6.10.1 Magnus Health(Veracross LLC) Corporation Information
6.10.2 Magnus Health(Veracross LLC) Description and Business Overview
6.10.3 Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Product Portfolio
6.10.5 Magnus Health(Veracross LLC) Recent Developments/Updates
6.11 Spago Nanomedical
6.11.1 Spago Nanomedical Corporation Information
6.11.2 Spago Nanomedical Gadolinium-based Contrast Media Description and Business Overview
6.11.3 Spago Nanomedical Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Spago Nanomedical Gadolinium-based Contrast Media Product Portfolio
6.11.5 Spago Nanomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadolinium-based Contrast Media Industry Chain Analysis
7.2 Gadolinium-based Contrast Media Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadolinium-based Contrast Media Production Mode & Process
7.4 Gadolinium-based Contrast Media Sales and 麻豆原创ing
7.4.1 Gadolinium-based Contrast Media Sales Channels
7.4.2 Gadolinium-based Contrast Media Distributors
7.5 Gadolinium-based Contrast Media Customers
8 Gadolinium-based Contrast Media 麻豆原创 Dynamics
8.1 Gadolinium-based Contrast Media Industry Trends
8.2 Gadolinium-based Contrast Media 麻豆原创 Drivers
8.3 Gadolinium-based Contrast Media 麻豆原创 Challenges
8.4 Gadolinium-based Contrast Media 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Bayer AG
GE Healthcare(GE)
Guerbet
Lantheus Medical Imaging
Bracco Diagnostics Inc.
Trivitron Healthcare
Nano Therapeutics Pvt. Ltd.
Nanoscan Imaging LLC
Jodas Expoim Pvt Ltd
Magnus Health(Veracross LLC)
Spago Nanomedical
听
听
*If Applicable.
